Admission Document - BrainJuicer
Admission Document - BrainJuicer
Admission Document - BrainJuicer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• Proprietary panel development. <strong>BrainJuicer</strong> has recently established and administers proprietary<br />
online panels for certain clients. The Directors are currently assessing the opportunity for expanding<br />
this development.<br />
• Innovation. <strong>BrainJuicer</strong> has a number of research initiatives which it is currently assessing with a<br />
view to these being trialled, written up as industry papers and tested with pioneering clients before<br />
being rolled out as finished <strong>BrainJuicer</strong> techniques.<br />
The Directors believe engagement by its multi national clients provides the market credibility necessary to<br />
compete effectively with the largest research agencies. <strong>BrainJuicer</strong> anticipates opportunities for further sales<br />
growth among multi-nationals and large domestics alike and intends to continue to build its portfolio of<br />
research products and develop its expertise, credibility and international presence.<br />
Summary financial information<br />
The following financial information has been extracted from the historical consolidated financial information<br />
on the <strong>BrainJuicer</strong> Group UK contained in Part IV of this document and should be read in conjunction with<br />
the full text of this document. Investors should not rely solely on the summarised information in making their<br />
investment decisions.<br />
2003 2004 2005<br />
£’000 £’000 £’000<br />
Turnover 1,032 2,614 2,936<br />
EBIT (304) 187 23<br />
EBT (301) 191 (17)<br />
Directors, senior management and employees<br />
The Board consists of four Directors in respect of whom brief biographies are set out below. Details of<br />
service contracts, option schemes and pension arrangements relating to the Directors are set out in<br />
paragraphs 5.1 and 5.3 of Part VII of this document.<br />
John Victor Kearon (aged 41), Chairman & Chief Executive Officer<br />
John is responsible for overall strategic direction and commercial development of the Group. John’s role in<br />
establishing and developing the <strong>BrainJuicer</strong> business made him Ernst & Young’s ‘Emerging Entrepreneur of<br />
the Year’ in 2005. Prior to founding <strong>BrainJuicer</strong>, John founded innovation agency, Brand Genetics Limited,<br />
which invented new products and services for FT 500 companies. Before this John had been Planning<br />
Director of one of the UK’s leading advertising agencies. John started his career over 20 years ago as a<br />
graduate of Unilever’s management programme, rising to be a senior marketer at Elida Gibbs before moving<br />
into advertising.<br />
James Brodie Geddes (aged 44), Chief Finance Officer<br />
James is responsible for the finance and administrative functions within the Group and its back office<br />
operations. James is a Chartered Accountant, holds a diploma in Corporate Treasury Management and is a<br />
graduate of Harvard Business School’s executive programme. He has over 20 years of financial management<br />
experience and was previously Assistant Treasurer of Fosters Brewing Group Limited, Executive Director,<br />
International Corporate Finance at MediaOne Group and CFO of Iobox Oy (backed by Morgan Stanley<br />
Capital and sold to Telefonica). James has been <strong>BrainJuicer</strong>’s CFO since the Unilever UK Holdings<br />
investment in January 2003.<br />
Mark Philip Muth (aged 52), Non-Executive Director<br />
Mark is one of the three directors of Unilever Ventures and negotiated Unilever UK Holdings’ investment in<br />
<strong>BrainJuicer</strong> in January 2003. He has over 20 years of experience in banking and venture capital. Unilever<br />
Ventures leads and manages investments in start-up and early stage companies, drawing on the Unilever<br />
group of companies’ expertise in food, home and personal care consumer products to bring value to its<br />
portfolio companies.<br />
15